E. Brandt

Journal of Clinical & Cellular Immunology · 2001–2011

A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from E. Brandt's perspective

Ordered by how strongly the researchers E. Brandt trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells (Nature Immunology)
  2. IL-22 producing “T22” T-cells account for up-regulated IL-22 in atopic dermatitis (AD), despite reduced IL-17 producing Th17 T-cells (Journal of Allergy and Clinical Immunology)
  3. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. (Journal of Clinical Investigation)
  4. IL-13 receptors and signaling pathways: an evolving web. (Journal of Allergy and Clinical Immunology)
  5. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cells (Journal of Experimental Medicine)
  6. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice (Nature Immunology)
  7. Epidermal barrier dysfunction in atopic dermatitis. (Journal of Investigative Dermatology)
  8. IL-31: a new link between T cells and pruritus in atopic skin inflammation. (Journal of Allergy and Clinical Immunology)
  9. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. (Immunity)
  10. Cytokine modulation of atopic dermatitis filaggrin skin expression. (Journal of Allergy and Clinical Immunology)

Their papers